Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
37,972,605
-
Total 13F shares
-
36,200,782
-
Share change
-
-814,665
-
Total reported value
-
$707,272,137
-
Put/Call ratio
-
26%
-
Price per share
-
$19.53
-
Number of holders
-
144
-
Value change
-
-$15,776,830
-
Number of buys
-
70
-
Number of sells
-
54
Institutional Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q4 2022
As of 31 Dec 2022,
iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) was held by
144 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,200,782 shares.
The largest 10 holders included
BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, Boxer Capital, LLC, VANGUARD GROUP INC, BVF INC/IL, BIOIMPACT CAPITAL LLC, STATE STREET CORP, CITADEL ADVISORS LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
144
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.